TG Therapeutics | Umlaufvermögen

Aktienkurs
30.09
Täglich Wechseln
-0.81 -2.62%
Monatlich
-0.73%
Jährlich
0%
Q1 Prognose
29.16




Umlaufvermögen Veränderung Datum
AbbVie USD 29.06B 523M 2025-12
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
Amgen USD 29.06B 1.17B 2025-12
Ardelyx USD 367.98M 16.42M 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
Bayer EUR 32.88B 873M 2025-09
Biogen USD 8.97B 37.5M 2025-12
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Curis USD 14.42M 10.39M 2025-06
Gilead Sciences USD 19.89B 1.05B 2025-12
Infinity Pharmaceuticals USD 19.91M 8.46M 2023-06
J&J USD 55.62B 1.01B 2025-12
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
Novartis USD 28.2B 2.26B 2025-09
Novavax USD 974.59M 55.08M 2025-09
PTC Therapeutics USD 2.27B 266.14M 2025-12
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
TG Therapeutics USD 630.76M 31M 2025-12
Verastem USD 124.7M 29.74M 2025-03
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12


TG Therapeutics Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.